Furthermore, we examined the correlation between SHOX2/RASSF1A methylation levels in plasma and clinicopathological variables such as gender, age, tumor pathologic classification, and degree of tumor differentiation; however, no significant associations were found. The gene discussed is RASSF1; the disease is neoplasm.